Page last updated: 2024-11-06

mitomycin and Esophageal Fistula

mitomycin has been researched along with Esophageal Fistula in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Esophageal Fistula: Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA.

Research Excerpts

ExcerptRelevanceReference
"Refractory esophageal stenosis (RES) is a major health problem in the pediatric population."1.43Management of refractory esophageal stenosis in the pediatric age. ( Alberca de Las Parras, F; Egea Valenzuela, J; Navalón Rubio, M, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberca de Las Parras, F1
Navalón Rubio, M1
Egea Valenzuela, J1

Other Studies

1 other study available for mitomycin and Esophageal Fistula

ArticleYear
Management of refractory esophageal stenosis in the pediatric age.
    Revista espanola de enfermedades digestivas, 2016, Volume: 108, Issue:10

    Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Drug Resistance; Esophageal Atresi

2016